More recently, the same results were observed in an exploratory study of phase II/III clinical trial assessing the effect of 75–300 mg of CBD in PD patients with restless leg syndrome and REM sleep disorder [87]. The gene discussed is OPN1MW; the disease is Parkinson disease.